Literature DB >> 15155835

Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents.

Tomohiko Ai1, Silvia G Bompadre, Xiaohui Wang, Shenghui Hu, Min Li, Tzyh-Chang Hwang.   

Abstract

To examine the effects of capsaicin on cystic fibrosis transmembrane conductance regulator (CFTR), we recorded wild-type and mutant CFTR chloride-channel currents using patch-clamp methods. The effects of capsaicin were compared with those of genistein, a well-characterized CFTR activator. In whole-cell experiments, capsaicin potentiates cAMP-stimulated wild-type CFTR currents expressed in NIH 3T3 cells or Chinese hamster ovary cells in a dose-dependent manner with a maximal response approximately 60% of that with genistein and an apparent Kd of 48.4 +/- 6.8 microM. In cell-attached recordings, capsaicin alone fails to activate CFTR in cells that show negligible basal CFTR activity, indicating that capsaicin does not stimulate the cAMP cascade. The magnitude of potentiation with capsaicin depends on the channel activity before drug application; the lower the prestimulated Po, the higher the potentiation. Single-channel kinetic analysis shows that capsaicin potentiates CFTR by increasing the opening rate and decreasing the closing rate of the channel. Capsaicin may act as a partial agonist of genistein because the maximally enhanced wild-type CFTR currents with genistein are partially inhibited by capsaicin. Capsaicin increases DeltaR-CFTR, a protein kinase A (PKA)-independent, constitutively active channel, in cell-attached patches. In excised inside-out patches, capsaicin potentiates the PKA-phosphorylated, ATP-dependent CFTR activity. Both capsaicin and genistein potentiate the cAMP-stimulated G551D-CFTR, DeltaF508-CFTR, and 8SA mutant channel currents. The binding site for capsaicin is probably located at the cytoplasmic domain of CFTR, because pipette application of capsaicin fails to potentiate CFTR activity. In conclusion, capsaicin is a partial agonist of genistein in activation of the CFTR chloride channel. Both compounds affect ATP-dependent gating of CFTR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155835     DOI: 10.1124/mol.65.6.1415

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  26 in total

1.  Modulation of cystic fibrosis transmembrane conductance regulator (CFTR) activity and genistein binding by cytosolic pH.

Authors:  Raffaella Melani; Valeria Tomati; Luis J V Galietta; Olga Zegarra-Moran
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  Curcumin and genistein additively potentiate G551D-CFTR.

Authors:  Ying-Chun Yu; Haruna Miki; Yumi Nakamura; Akiko Hanyuda; Yohei Matsuzaki; Yoichiro Abe; Masato Yasui; Kazuhiko Tanaka; Tzyh-Chang Hwang; Silvia G Bompadre; Yoshiro Sohma
Journal:  J Cyst Fibros       Date:  2011-03-26       Impact factor: 5.482

Review 3.  Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis.

Authors:  Zhi-wei Cai; Jia Liu; Hong-yu Li; David N Sheppard
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

4.  CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR.

Authors:  Yiting Wang; Jia Liu; Avgi Loizidou; Luc A Bugeja; Ross Warner; Bethan R Hawley; Zhiwei Cai; Ashley M Toye; David N Sheppard; Hongyu Li
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

5.  Characterization of a 7,8-benzoflavone double effect on CFTR Cl(-) channel activity.

Authors:  Loretta Ferrera; Chiara Pincin; Oscar Moran
Journal:  J Membr Biol       Date:  2007-09-18       Impact factor: 1.843

Review 6.  Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.

Authors:  James L Kreindler
Journal:  Pharmacol Ther       Date:  2009-11-10       Impact factor: 12.310

7.  Direct effects of 9-anthracene compounds on cystic fibrosis transmembrane conductance regulator gating.

Authors:  Tomohiko Ai; Silvia G Bompadre; Yoshiro Sohma; Xiaohui Wang; Min Li; Tzyh-Chang Hwang
Journal:  Pflugers Arch       Date:  2004-10       Impact factor: 3.657

Review 8.  Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications.

Authors:  Yoshiro Sohma; Ying-Chun Yu; Tzyh-Chang Hwang
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Chimeric constructs endow the human CFTR Cl- channel with the gating behavior of murine CFTR.

Authors:  Toby S Scott-Ward; Zhiwei Cai; Elizabeth S Dawson; Ann Doherty; Ana Carina Da Paula; Heather Davidson; David J Porteous; Brandon J Wainwright; Margarida D Amaral; David N Sheppard; A Christopher Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

10.  Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator.

Authors:  A Schmidt; L K Hughes; Z Cai; F Mendes; H Li; D N Sheppard; M D Amaral
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.